StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.64+0.02 (+1.23%)

Close on Nov 17, 2026Market cap $11.80MP/E 1.1Yield –

Chemomab Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Chemomab Therapeutics

Chemomab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Chemomab Therapeutics figures

See a number that looks wrong?